Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study

• Michael Hardy,
• Isabelle Michaux,
• Alain Dive,
• Thomas Lecompte,
• François Mullier

Affiliations

Michael Hardy

Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium

Isabelle Michaux

Université catholique de Louvain, CHU UCL Namur, Intensive Care Department, Yvoir, Belgium

Alain Dive

Université catholique de Louvain, CHU UCL Namur, Intensive Care Department, Yvoir, Belgium

Thomas Lecompte

Division of Angiology and Hemostasis - Geneva Platelet Group, Departement of Medicine, Université de Genève et Hôpitaux Universitaires de Genève, Geneva, Switzerland

François Mullier

Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium